State-of-the-art nanotechnologies for the detection, recovery, analysis and elimination of liquid biopsy components in cancer
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Extracellular vesicles in disease · Cancer Cells and Metastasis · Nanopore and Nanochannel Transport Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2. Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers10.1038/s41591-019-0561-9 ↗
3. Circulating tumour cells and circulating free nucleic acid as prognostic and predictive biomarkers in colorectal cancer10.1016/j.canlet.2013.12.019 ↗
4. Plasma-metabolite-based machine learning is a promising diagnostic approach for esophageal squamous cell carcinoma investigation10.1016/j.jpha.2020.11.009 ↗
5. Clinical utility of circulating tumor cells: an update10.1002/1878-0261.12869 ↗
6. Serum tumour markers: how to order and interpret them10.1136/bmj.b3527 ↗
7. Molecular characterization of circulating tumor cells-from bench to bedside10.1016/j.semcdb.2017.09.013 ↗
8. Circulating tumor cell isolation, culture, and downstream molecular analysis10.1016/j.biotechadv.2018.03.007 ↗
9. Circulating tumor cells: from theory to nanotechnology-based detection10.3389/fphar.2017.00035 ↗
10. Nano-bio interactions in cancer: from therapeutics delivery to early detection10.1021/acs.accounts.0c00413 ↗
11. Aptamer-based nanostructured interfaces for the detection and release of circulating tumor cells10.1039/C9TB02457C ↗
12. NanoVelcro rare-cell assays for detection and characterization of circulating tumor cells10.1016/j.addr.2018.03.006 ↗
13. Advanced nanotechnologies for extracellular vesicle-based liquid biopsy10.1002/advs.202102789 ↗
14. Engineering state-of-the-art plasmonic nanomaterials for SERS-based clinical liquid biopsy applications10.1002/advs.201900730 ↗
15. Circulating tumor cells and circulating tumor DNA: challenges and opportunities on the path to clinical utility10.1158/1078-0432.CCR-14-1190 ↗
16. Circulating tumor cells10.1073/pnas.1304186110 ↗
17. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay10.1038/nbt.2576 ↗
18. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer10.1200/JCO.2007.15.8923 ↗
19. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer10.1158/1078-0432.CCR-08-0872 ↗
20. Negative depletion mediated brightfield circulating tumour cell identification strategy on microparticle-based microfluidic chip10.1186/s12951-020-00623-4 ↗
21. Portable filter-based microdevice for detection and characterization of circulating tumor cells10.1158/1078-0432.CCR-10-1105 ↗
22. Detection of circulating tumor cells in blood using an optimized density gradient centrifugation10.1007/978-3-642-59349-9_13 ↗
23. Microsieve lab-chip device for rapid enumeration and fluorescence in situ hybridization of circulating tumor cells10.1039/c2lc20750h ↗
24. Continuous dielectrophoretic cell separation microfluidic device10.1039/B613344D ↗
25. Effective capture of circulating tumor cells from an S180-bearing mouse model using electrically charged magnetic nanoparticles10.1186/s12951-019-0491-1 ↗
26. Size-based separation methods of circulating tumor cells10.1016/j.addr.2018.01.002 ↗
27. Continuous flow deformability-based separation of circulating tumor cells using microfluidic ratchets10.1002/smll.201503639 ↗
28. Functional studies on viable circulating tumor cells10.1373/clinchem.2015.242537 ↗
29. Technologies for label-free separation of circulating tumor cells: from historical foundations to recent developments10.1039/C3LC50625H ↗
30. Review: isolation and detection of tumor-derived extracellular vesicles10.1021/acsanm.8b00267 ↗
31. The biology, function, and biomedical applications of exosomes10.1126/science.aau6977 ↗
32. Isolation of exosomes from whole blood by a new microfluidic device: proof of concept application in the diagnosis and monitoring of pancreatic cancer10.1186/s12951-020-00701-7 ↗
33. Manipulating endogenous exosome biodistribution for therapy10.1002/smm2.1043 ↗
34. Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis10.1038/ncomms15016 ↗
35. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver10.1038/ncb3169 ↗
36. Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles10.1126/sciadv.aar2766 ↗
37. Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways10.1016/j.cell.2014.09.051 ↗
38. Tumor-derived exosomes: Nanovesicles made by cancer cells to promote cancer metastasis10.1016/j.apsb.2021.04.012 ↗
39. Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression10.1038/s41565-017-0012-z ↗
40. Cell-derived vesicles for drug therapy and diagnostics: opportunities and challenges10.1016/j.nantod.2015.04.004 ↗
41. Extracellular vesicles: exosomes, microvesicles, and friends10.1083/jcb.201211138 ↗
42. The emerging role of extracellular vesicles as biomarkers for urogenital cancers10.1038/nrurol.2014.301 ↗
43. Liquid biopsies in cancer diagnosis, monitoring, and prognosis10.1016/j.tips.2019.01.006 ↗
44. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer10.1038/nature14581 ↗
45. Ultra-sensitive liquid biopsy of circulating extracellular vesicles using exoscreen10.1038/ncomms4591 ↗
46. Unveiling massive numbers of cancer-related urinary-microRNA candidates via nanowires10.1126/sciadv.1701133 ↗
47. Exosomal miR-34s panel as potential novel diagnostic and prognostic biomarker in patients with hepatoblastoma10.1016/j.jpedsurg.2016.09.070 ↗
48. Recent progress in isolation and detection of extracellular vesicles for cancer diagnostics10.1002/adhm.201800484 ↗
49. Reproducibility and efficiency of serum-derived exosome extraction methods10.1016/j.clinbiochem.2014.06.011 ↗
50. Benchtop isolation and characterization of functional exosomes by sequential filtration10.1016/j.chroma.2014.10.026 ↗
51. Exosome isolation by ultracentrifugation and precipitation and techniques for downstream analyses10.1002/cpcb.110 ↗
52. Towards microfluidic-based exosome isolation and detection for tumor therapy10.1016/j.nantod.2020.101066 ↗
53. Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes10.1016/j.ymeth.2012.01.002 ↗
54. Comparative analysis of exosome isolation methods using culture supernatant for optimum yield, purity and downstream applications10.1038/s41598-019-41800-2 ↗
55. An integrated microfluidic system for on-chip enrichment and quantification of circulating extracellular vesicles from whole blood10.1039/C9LC00624A ↗
56. Exodisc for rapid, size-selective, and efficient isolation and analysis of nanoscale extracellular vesicles from biological samples10.1021/acsnano.6b06131 ↗
57. Isolation and recovery of extracellular vesicles using optically-induced dielectrophoresis on an integrated microfluidic platform10.1039/D1LC00093D ↗
58. Cell-free nucleic acids as biomarkers in cancer patients10.1038/nrc3066 ↗
59. Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-Of-origin10.1016/j.cell.2015.11.050 ↗
60. Nanotechnology strategies for the analysis of circulating tumor dna: a review
61. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells
62. Liquid biopsy and minimal residual disease - latest advances and implications for cure10.1038/s41571-019-0187-3 ↗
63. MicroRNA biogenesis: coordinated cropping and dicing10.1038/nrm1644 ↗
64. Current and future perspectives of liquid biopsies in genomics-driven oncology10.1038/s41576-018-0071-5 ↗
65. Circulating cancer biomarkers: the macro-revolution of the Micro-RNA10.1016/j.ebiom.2016.02.038 ↗
66. MicroRNA expression profiles classify human cancers10.1038/nature03702 ↗
67. A novel quantification platform for point-of-care testing of circulating MicroRNAs based on allosteric spherical nanoprobe10.1186/s12951-020-00717-z ↗
68. Thrombocytosis associated with malignant disease10.1001/archinte.1964.03860100079008 ↗
69. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis10.1016/j.ccr.2011.09.009 ↗
70. Blood platelets contain tumor-derived RNA biomarkers10.1182/blood-2011-03-344408 ↗
71. Platelets govern pre-metastatic tumor communication to bone10.1038/onc.2012.447 ↗
72. RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics10.1016/j.ccell.2015.09.018 ↗
73. RNA sequencing and swarm intelligence-enhanced classification algorithm development for blood-based disease diagnostics using spliced blood platelet RNA10.1038/s41596-019-0139-5 ↗
74. Clinical verification of vimentin/EpCAM immunolipid magnetic sorting system in monitoring CTCs in arterial and venous blood of advanced tumor10.1186/s12951-021-00929-x ↗
75. Tumor heterogeneity and circulating tumor cells10.1016/j.canlet.2016.02.024 ↗
76. Epithelial cell adhesion molecule: an anchor to isolate clinically relevant circulating tumor cells10.3390/cells9081836 ↗
77. High sensitive detection of circulating tumor cell by multimarker lipid magnetic nanoparticles and clinical verifications10.1186/s12951-019-0548-1 ↗
78. Recent progress in the molecular imaging of therapeutic monoclonal antibodies10.1016/j.jpha.2020.07.006 ↗
79. Emerging Nanotechnologies for Liquid Biopsy: The Detection of Circulating Tumor Cells and Extracellular Vesicles10.1002/adma.201970318 ↗
80. Plasma extracellular vesicles detected by Single Molecule array technology as a liquid biopsy for colorectal cancer
81. Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring10.1038/s41467-020-18311-0 ↗
82. Phosphoproteins in extracellular vesicles as candidate markers for breast cancer10.1073/pnas.1618088114 ↗
83. Increased PSA expression on prostate cancer exosomes in in vitro condition and in cancer patients10.1016/j.canlet.2017.06.036 ↗
84. Magnetic particles for CTC enrichment10.3390/cancers12123525 ↗
85. Emerging role of nanomaterials in circulating tumor cell isolation and analysis10.1021/nn5004277 ↗
86. Selective isolation of magnetic nanoparticle-mediated heterogeneity subpopulation of circulating tumor cells using magnetic gradient based microfluidic system10.1016/j.bios.2016.08.002 ↗
87. Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data10.1016/S1470-2045(14)70069-5 ↗
88. Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data10.1016/S1470-2045(08)70340-1 ↗
89. Multifunctional magnetic particles for combined circulating tumor cells isolation and cellular metabolism detection10.1002/adfm.201504184 ↗
90. Clinical utility of non-EpCAM based circulating tumor cell assays10.1016/j.addr.2018.01.013 ↗
91. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition10.1186/1471-2407-12-178 ↗
92. The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis10.1126/scitranslmed.3005109 ↗
93. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition10.1126/science.1228522 ↗
94. High-efficiency isolation and rapid identification of heterogeneous circulating tumor cells (ctcs) using dual-antibody-modified fluorescent-magnetic nanoparticles10.1021/acsami.9b14051 ↗
95. Replacing antibodies with aptamers in lateral flow immunoassay10.1016/j.bios.2015.04.041 ↗
96. Aptamers as targeted therapeutics: current potential and challenges10.1038/nrd.2017.86 ↗
97. Surface-immobilized aptamers for cancer cell isolation and microscopic cytology10.1158/0008-5472.CAN-10-0568 ↗
98. Selection of metastatic breast cancer cell-specific aptamers for the capture of ctcs with a metastatic phenotype by cell-SELEX10.1016/j.omtn.2018.07.008 ↗
99. Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture10.1021/ac400366b ↗
100. Aptamer-conjugated graphene oxide membranes for highly efficient capture and accurate identification of multiple types of circulating tumor cells10.1021/bc500503e ↗